Morgan Stanley’s Leap Therapeutics LPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$188 Sell
634
-571
-47% -$169 ﹤0.01% 7579
2025
Q1
$367 Sell
1,205
-207
-15% -$63 ﹤0.01% 7410
2024
Q4
$4.06K Buy
1,412
+344
+32% +$989 ﹤0.01% 7055
2024
Q3
$2.75K Hold
1,068
﹤0.01% 7067
2024
Q2
$2.09K Sell
1,068
-25
-2% -$49 ﹤0.01% 7057
2024
Q1
$2.91K Sell
1,093
-1,419
-56% -$3.78K ﹤0.01% 7009
2023
Q4
$10.4K Buy
2,512
+1,520
+153% +$6.3K ﹤0.01% 6828
2023
Q3
$1.37K Sell
992
-100
-9% -$138 ﹤0.01% 7190
2023
Q2
$3.42K Buy
1,092
+59
+6% +$185 ﹤0.01% 7069
2023
Q1
$3.51K Buy
1,033
+41
+4% +$139 ﹤0.01% 7139
2022
Q4
$4.46K Sell
992
-6,871
-87% -$30.9K ﹤0.01% 7171
2022
Q3
$70K Buy
7,863
+117
+2% +$1.04K ﹤0.01% 6248
2022
Q2
$89K Sell
7,746
-62,189
-89% -$715K ﹤0.01% 6336
2022
Q1
$1.22M Buy
69,935
+39,932
+133% +$699K ﹤0.01% 4861
2021
Q4
$972K Buy
30,003
+17,828
+146% +$578K ﹤0.01% 5090
2021
Q3
$489K Buy
12,175
+3,987
+49% +$160K ﹤0.01% 5508
2021
Q2
$134K Buy
8,188
+4,347
+113% +$71.1K ﹤0.01% 6208
2021
Q1
$73K Buy
3,841
+3,840
+384,000% +$73K ﹤0.01% 6170
2020
Q4
$0 Sell
1
-600
-100% ﹤0.01% 7072
2020
Q3
$12K Sell
601
-400
-40% -$7.99K ﹤0.01% 6215
2020
Q2
$21K Buy
1,001
+1,000
+100,000% +$21K ﹤0.01% 5995
2020
Q1
$0 Sell
1
-1
-50% ﹤0.01% 6640
2019
Q4
$0 Buy
2
+1
+100% ﹤0.01% 6709
2019
Q3
$0 Hold
1
﹤0.01% 6701
2019
Q2
$0 Sell
1
-3
-75% ﹤0.01% 6702
2019
Q1
$0 Sell
4
-2
-33% ﹤0.01% 6655
2018
Q4
$0 Sell
6
-5
-45% ﹤0.01% 6668
2018
Q3
$1K Buy
+11
New +$1K ﹤0.01% 6631
2017
Q3
Sell
-50
Closed -$3K 6572
2017
Q2
$3K Buy
+50
New +$3K ﹤0.01% 6416